Cell Source, Inc.: operating expenses
Operating expenses for Cell Source, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Cell Source, Inc. financial histories
What this measure means
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
Exact concept: us-gaap:OperatingExpenses. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2013-01-01 to 2024-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-01-01 | 2024-12-31 | 3,840,244 | USD | 2026-04-07 | 10-K · 0001493152-26-015359 |
| 2023-01-01 | 2023-12-31 | 4,325,346 | USD | 2026-04-07 | 10-K · 0001493152-26-015359 |
| 2022-01-01 | 2022-12-31 | 4,175,333 | USD | 2024-06-24 | 10-K · 0001493152-24-024903 |
| 2021-01-01 | 2021-12-31 | 4,018,572 | USD | 2023-08-08 | 10-K · 0001493152-23-027069 |
| 2020-01-01 | 2020-12-31 | 3,638,036 | USD | 2022-04-15 | 10-K · 0001493152-22-010133 |
| 2019-01-01 | 2019-12-31 | 3,805,201 | USD | 2021-04-15 | 10-K · 0001640334-21-000923 |
| 2018-01-01 | 2018-12-31 | 2,006,143 | USD | 2020-03-30 | 10-K · 0001640334-20-000672 |
| 2017-01-01 | 2017-12-31 | 2,292,803 | USD | 2019-04-01 | 10-K · 0001165527-19-000034 |
| 2016-01-01 | 2016-12-31 | 2,318,606 | USD | 2018-07-25 | 10-K · 0001165527-18-000154 |
| 2015-01-01 | 2015-12-31 | 2,320,475 | USD | 2018-07-25 | 10-K · 0001165527-18-000154 |
| 2014-01-01 | 2014-12-31 | 4,054,066 | USD | 2016-04-14 | 10-K · 0001165527-16-000733 |
| 2013-01-01 | 2013-12-31 | 1,455,370 | USD | 2015-03-13 | 10-K · 0001144204-15-015954 |
Related financial histories
- Cell Source, Inc.: total assets
- Cell Source, Inc.: total liabilities
- Cell Source, Inc.: stockholders equity
- Cell Source, Inc.: cash and cash equivalents
- Cell Source, Inc.: net income or loss
- Cell Source, Inc.: operating cash flow
- Cell Source, Inc.: financing cash flow
- Cell Source, Inc.: retained earnings or deficit
- Cell Source, Inc.: basic weighted-average shares
- Cell Source, Inc.: diluted weighted-average shares
- Cell Source, Inc.: basic earnings per share
- Cell Source, Inc.: diluted earnings per share
- Cell Source, Inc.: net property, plant and equipment
- Cell Source, Inc.: share-based compensation expense
- Cell Source, Inc.: operating income or loss
- Cell Source, Inc.: current assets
- Cell Source, Inc.: interest expense
- Cell Source, Inc.: current liabilities
- Cell Source, Inc.: current accounts payable
- Cell Source, Inc.: selling, general and administrative expense
- Cell Source, Inc.: research and development expense
Inspect the source
- Entity
- Cell Source, Inc. / CIK 0001569340
- Captured
- 2026-09-20T09:20:59.488Z
- SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))